Opthea Ltd (ASX:OPT)
A$ 0.815 0.03 (3.82%) Market Cap: 1.00 Bil Enterprise Value: 956.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Opthea Ltd at H C Wainwright Ophthalmology Virtual Conference Transcript

Aug 17, 2022 / NTS GMT
Release Date Price: A$1.11 (+2.00%)
Trevor Levy
H.C. Wainwright & Co., LLC - Analyst

Good afternoon, everyone, and thank you for joining H.C. Wainwright's Second Annual Ophthalmology Conference. My name is Trevor levy and I'm on corporate access team at H.C. Wainwright. H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. We have a total of 26 publishing analysts and 643 companies covered across all sectors. Please visit hcwco.com for more information.

Please join us for one-on-one meetings, corporate presentations, and panels that will be available live and streaming on August 17. With that said, have a productive and enjoyable day. And I'd like to introduce our presenter, please welcome Megan Baldwin, CEO of Opthea Limited.

Megan Baldwin
Opthea Limited - CEO & Managing Director

Thanks very much. And thank you very much to H.C. Wainwright for this opportunity to talk about Opthea and our eye disease therapeutic OPT-302.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot